Status:

UNKNOWN

Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

Association Française contre les Myopathies (AFM), Paris

Conditions:

Myopathy

Muscular Weakness

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a multicenter randomized controlled open labeled study testing efficacy and tolerance of early launching of night non invasive ventilation in patients with myotonic dystrophy type 1(DM1). The ...

Detailed Description

DM1 is the most frequent genetic myopathy in the adult. Actually there is no curative treatment, and symptomatic cares are essentials. The respiratory impairment is the main cause of morbid-mortality ...

Eligibility Criteria

Inclusion

  • Man or woman of age ≥ 18 years
  • Preliminary medical examination
  • Enlightened and written consent
  • Genetically proved Steinert disease
  • Presenting at least one of the following 3 criteria
  • A hypercapnia: PaCO2 \> 45 mmHg or
  • A night-desaturation: SaO2 \< 88 % more than consecutive 5 minutes or
  • Apnea syndrome with significant sleep:index of apnea / hypopnea\> a 30 / hour
  • And with presence of at least a clinical sign: dyspnoea, orthopnea, headaches, asthenia, diurnal sleepiness, or any other sign suggestive of disturbance of the sleep or of respiratory dysfunction

Exclusion

  • Age inferior to 18
  • Regime of legal protection
  • Pregnancy
  • Absolute indication for ventilation: clinical signs (dyspnoea, orthopnea, headaches, asthenia, diurnal sleepiness), AND PaCO2 \> 60 mmHg, AND night-desaturation \< 88 % AND one CV \< 50 % of the theoretical or the PIMAX \< 60 cm H2O
  • Acute respiratory failure
  • Already ventilated patient
  • Patient under oxygen
  • Not (beneficiary to a regime of Social Security or legal successor)

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2018

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT01225614

Start Date

October 1 2010

End Date

December 1 2018

Last Update

November 20 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Home ventilation unit and intensive care, centre of neuromuscular disease (Garches Mondor Necker Hendaye), Raymond Poincaré hospital Versailles Saint Quentin University.

Garches, France, 92380

Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive | DecenTrialz